Corsten, Cato E. A.
Marques, Ana M.
Masmanidou, Despoina
Ikram, M. Kamran
van Luijn, Marvin M.
Wokke, Beatrijs
Smolders, Joost
Funding for this research was provided by:
Nationaal MS fonds (P2021-001)
Stichting MOVES ‘Klimmen tegen MS’ (Inspiratiebeurs)
Article History
Received: 4 February 2025
Accepted: 22 August 2025
First Online: 26 September 2025
Declarations
:
: M. van Luijn received research support from EMD Serono, Merck, Novartis, GSK and Idorsia Pharmaceutical Ltd. J. Smolders reports grants for scientific research from Biogen, Roche and Siemens Healthineers and received speaker and/or consultancy fee of Biogen, Merck, Novartis, Roche and Sanofi. All the remaining authors declare no conflict of interest.